Prediction of histone deacetylase inhibition by triazole compounds based on artificial intelligence

2Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A quantitative structure-activity relationship (QSAR) study was conducted to predict the anti-colon cancer and HDAC inhibition of triazole-containing compounds. Four descriptors were selected from 579 descriptors which have the most obvious effect on the inhibition of histone deacetylase (HDAC). Four QSAR models were constructed using heuristic algorithm (HM), random forest (RF), radial basis kernel function support vector machine (RBF-SVM) and support vector machine optimized by particle swarm optimization (PSO-SVM). Furthermore, the robustness of four QSAR models were verified by K-fold cross-validation method, which was described by Q2. In addition, the R2 of the four models are greater than 0.8, which indicates that the four descriptors selected are reasonable. Among the four models, model based on PSO-SVM method has the best prediction ability and robustness with R2 of 0.954, root mean squared error (RMSE) of 0.019 and Q2 of 0.916 for the training set and R2 of 0.965, RMSE of 0.017 and Q2 of 0.907 for the test set. In this study, four key descriptors were discovered, which will help to screen effective new anti-colon cancer drugs in the future.

Cite

CITATION STYLE

APA

Wang, Y., & Zhang, P. (2023). Prediction of histone deacetylase inhibition by triazole compounds based on artificial intelligence. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1260349

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free